{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:05:51Z","timestamp":1784279151872,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05586-y","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:28:23Z","timestamp":1780396103000},"page":"3085-3100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MELK inhibits cuproptosis in diffuse large B-cell lymphoma cells via the PI3K\/mTOR\/S6K-DLAT signaling axis"],"prefix":"10.1007","volume":"481","author":[{"given":"Xiaoxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meineng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"1","key":"5586_CR1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.84733","volume":"20","author":"K-H Tsui","year":"2024","unstructured":"Tsui K-H, Hsiao J-H, Lin L-T, Tsang Y-L, Shao A-N, Kuo C-H et al (2024) The cross-communication of cuproptosis and regulated cell death in human pathophysiology. Int J Biol Sci 20(1):218","journal-title":"Int J Biol Sci"},{"key":"5586_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1504802","volume":"17","author":"M Aschner","year":"2024","unstructured":"Aschner M, Skalny AV, Lu R, Martins AC, Tizabi Y, Nekhoroshev SV et al (2024) Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy. Front Mol Neurosci 17:1504802","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"5586_CR3","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X (2023) Copper metabolism in cell death and autophagy. Autophagy 19(8):2175\u20132195","journal-title":"Autophagy"},{"issue":"6","key":"5586_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3202","volume":"42","author":"A Barraclough","year":"2024","unstructured":"Barraclough A, Hawkes E, Sehn LH, Smith SM (2024) Diffuse large B-cell lymphoma. Hematol Oncol 42(6):e3202","journal-title":"Hematol Oncol"},{"key":"5586_CR5","doi-asserted-by":"crossref","unstructured":"Meng X, Min Q, Wang J-Y (2020) B cell lymphoma. B Cells in Immun Tolerance. 161\u2009\u2013\u200981","DOI":"10.1007\/978-981-15-3532-1_12"},{"key":"5586_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102443","volume":"110","author":"S Poletto","year":"2022","unstructured":"Poletto S, Novo M, Paruzzo L, Frascione PMM, Vitolo U (2022) Treatment strategies for patients with diffuse large B-cell lymphoma. Cancer Treat Rev 110:102443","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5586_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17305\/bb.2024.10536","volume":"25","author":"J Xie","year":"2024","unstructured":"Xie J, Shao Z, Li C, Zeng C, Xu B (2024) Cuproptosis-related gene ATOX1 promotes MAPK signaling and diffuse large B-cell lymphoma proliferation via modulating copper transport. Biomolecules Biomed 25(1):16","journal-title":"Biomolecules Biomed"},{"key":"5586_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1020566","volume":"12","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhang T, Zheng Z, Lin Z, Wang Q, Zheng D et al (2023) Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Front Oncol 12:1020566","journal-title":"Front Oncol"},{"key":"5586_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/biology15020200","volume":"15","author":"AM Alzeer","year":"2025","unstructured":"Alzeer AM, Allahham S (2025) Maternal Embryonic Leucine Zipper Kinase (MELK) in cancer: biological functions, therapeutic potential, and controversies. Biology 15:200","journal-title":"Biology"},{"issue":"11","key":"5586_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou H, Zhai X, Gao L, Yang M, An B et al (2023) MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis 14(11):733","journal-title":"Cell Death Dis"},{"key":"5586_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2021.06.012","volume":"172","author":"B Tang","year":"2021","unstructured":"Tang B, Zhu J, Fang S, Wang Y, Vinothkumar R, Li M et al (2021) Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. Free Radic Biol Med 172:312\u2013329","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"5586_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03453-8","volume":"24","author":"P Su","year":"2024","unstructured":"Su P, Yu T, Zhang Y, Huang H, Chen M, Cao C et al (2024) Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1\/JAK2\/STAT3 pathway in gastric cancer. Cancer Cell Int 24(1):287","journal-title":"Cancer Cell Int"},{"issue":"12","key":"5586_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0249-x","volume":"9","author":"A Maes","year":"2019","unstructured":"Maes A, Maes K, Vlummens P, De Raeve H, Devin J, Szablewski V et al (2019) Maternal embryonic leucine zipper kinase is a novel target for diffuse large b cell lymphoma and mantle cell lymphoma. Blood Cancer J 9(12):87","journal-title":"Blood Cancer J"},{"issue":"1","key":"5586_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y (2022) Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Experimental Clin Cancer Res 41(1):271","journal-title":"J Experimental Clin Cancer Res"},{"issue":"8","key":"5586_CR15","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1158\/2767-9764.CRC-23-0631","volume":"4","author":"CA Behrmann","year":"2024","unstructured":"Behrmann CA, Ennis KN, Sarma P, Wetzel C, Clark NA, Von Handorf KM et al (2024) Coordinated targeting of S6K1\/2 and AXL disrupts pyrimidine biosynthesis in PTEN-deficient glioblastoma. Cancer Res Commun 4(8):2215\u20132227","journal-title":"Cancer Res Commun"},{"issue":"1","key":"5586_CR16","first-page":"1","volume":"16","author":"A Berhan","year":"2025","unstructured":"Berhan A, Almaw A, Damtie S, Solomon Y (2025) Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review. Discover Oncol 16(1):1\u201315","journal-title":"Discover Oncol"},{"key":"5586_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.594782","volume":"10","author":"M B\u00f6ttcher","year":"2020","unstructured":"B\u00f6ttcher M, Baur R, Stoll A, Mackensen A, Mougiakakos D (2020) Linking immunoevasion and metabolic reprogramming in B-cell\u2013derived lymphomas. Front Oncol 10:594782","journal-title":"Front Oncol"},{"key":"5586_CR18","doi-asserted-by":"crossref","unstructured":"Liu X, Wang J, Wang Y, Zhang X, Liu G, Li H et al (2020) MELK inhibition effectively suppresses growth of glioblastoma and cancer stem-like cells by blocking AKT and FOXM1 pathways","DOI":"10.21203\/rs.3.rs-26425\/v1"},{"issue":"3","key":"5586_CR19","first-page":"739","volume":"31","author":"J-Y Zhou","year":"2023","unstructured":"Zhou J-Y, Huang H, Zhuang Y, Zhong X-M (2023) Effect of MELK inhibitor OTSSP167 on diffuse large B-cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 31(3):739\u2013745","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"5586_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63433-w","volume":"14","author":"X Bai","year":"2024","unstructured":"Bai X, Lu F, Li S, Zhao Z, Wang N, Zhao Y et al (2024) Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large b cell lymphoma. Sci Rep 14(1):12926","journal-title":"Sci Rep"},{"issue":"2","key":"5586_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70602","volume":"14","author":"ZZ Zhou","year":"2025","unstructured":"Zhou ZZ, Lu JC, Guo SB, Tian XP, Li HL, Zhou H et al (2025) A mitochondria-related signature in diffuse large B\u2010Cell lymphoma: prognosis, immune and therapeutic features. Cancer Med 14(2):e70602","journal-title":"Cancer Med"},{"issue":"9","key":"5586_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00262-025-04150-9","volume":"74","author":"J Wu","year":"2025","unstructured":"Wu J, Deng Y, Gao Y, Wei B (2025) Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity. Cancer Immunol Immunother 74(9):293","journal-title":"Cancer Immunol Immunother"},{"issue":"35","key":"5586_CR23","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.2174\/1381612826666200628022113","volume":"26","author":"M Rieber","year":"2020","unstructured":"Rieber M (2020) Cancer pro-oxidant therapy through copper redox cycling: repurposing disulfiram and tetrathiomolybdate. Curr Pharm Des 26(35):4461\u20134466","journal-title":"Curr Pharm Des"},{"issue":"12","key":"5586_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tips.2023.08.012","volume":"44","author":"C Scarpellini","year":"2023","unstructured":"Scarpellini C, Klejborowska G, Lanthier C, Hassannia B, Vanden Berghe T, Augustyns K (2023) Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors. Trends Pharmacol Sci 44(12):902\u2013916","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"5586_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"C-H Lin","year":"2024","unstructured":"Lin C-H, Chin Y, Zhou M, Sobol RW, Hung M-C, Tan M (2024) Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci 49(8):729\u2013744","journal-title":"Trends Biochem Sci"},{"key":"5586_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.09.044","author":"Y He","year":"2025","unstructured":"He Y, Yi T, Yao Y, Duan S, Wang L, Gao J et al (2025) Targeting FDX1 with Icaritin attenuates neuronal cuproptosis by reconciling mitochondrial fission-fusion dynamics and bioenergetic homeostasis. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.044","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5586_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1677\/erc.0.0110255","volume":"11","author":"V Goodman","year":"2004","unstructured":"Goodman V, Brewer G, Merajver S (2004) Copper deficiency as an anti-cancer strategy. Endocrine-related Cancer 11(2):255\u2013263","journal-title":"Endocrine-related Cancer"},{"key":"5586_CR28","first-page":"363","volume":"1000","author":"P Cutillas","year":"2019","unstructured":"Cutillas P, Kessler BM (2019) Proteomics and metabolomics applications in cancer biology. Oxf Textbook Cancer Biology 1000:363","journal-title":"Oxf Textbook Cancer Biology"},{"issue":"5","key":"5586_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/10409238.2021.1934811","volume":"56","author":"M Cirone","year":"2021","unstructured":"Cirone M (2021) Cancer cells dysregulate PI3K\/AKT\/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses. Crit Rev Biochem Mol Biol 56(5):500\u2013509","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"5586_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41375-022-01749-0","volume":"37","author":"W Xu","year":"2023","unstructured":"Xu W, Berning P, Erdmann T, Grau M, Bettazov\u00e1 N, Zapukhlyak M et al (2023) mTOR inhibition amplifies the anti-lymphoma effect of PI3K\u03b2\/\u03b4 blockage in diffuse large B-cell lymphoma. Leukemia 37(1):178\u2013189","journal-title":"Leukemia"},{"issue":"28","key":"5586_CR31","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.2174\/0929867327666200114113139","volume":"27","author":"N Zhang","year":"2020","unstructured":"Zhang N, Ma S (2020) Research progress of 70\u00a0kDa ribosomal protein S6 kinase (P70S6K) inhibitors as effective therapeutic tools for obesity, type II diabetes and cancer. Curr Med Chem 27(28):4699\u20134719","journal-title":"Curr Med Chem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05586-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05586-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05586-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:24:24Z","timestamp":1784276664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05586-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5586"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05586-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}